SCHEMBL1102848

SCHEMBL1102848

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccccc3-c3ccccc3)c3ncccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 4/20 0.44
CKS1B P61024 4/20 0.42
SKP2 Q13309 4/20 0.42
GLO1 Q04760 2/20 0.42
ENPP1 P22413 1/20 0.40
HSP90AA1 P07900 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 1/20 0.38
CCR1 P32246 3/20 0.38
CCR8 P51685 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HTT P42858 2/20 0.38
GMNN O75496 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MMP2 P08253 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102974 0.97 TOP1 (0.41) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1103042 0.95 TOP1 (0.42) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1103002 0.92 TOP1 (0.41) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1103197 0.91 TNF (0.43) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1102930 0.89 CKS1B (0.49) TOP1CKS1BSKP2GLO1HSP90AA1
SCHEMBL1103202 0.88 TNF (0.41) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1103187 0.84 TNF (0.46) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1102984 0.84 CKS1B (0.48) TOP1CKS1BSKP2GLO1ENPP1
SCHEMBL1103135 0.84 TOP1 (0.41) TOP1HSP90AA1L3MBTL1CCR1CCR8
SCHEMBL1103101 0.84 CKS1B (0.43) TOP1CKS1BSKP2GLO1ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TOP1 4307/4885CKS1B 3839/4885SKP2 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.